KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Johnson & Johnson (JNJ) over the last 17 years, with Q3 2025 value amounting to -$270.0 million.

  • Johnson & Johnson's Change in Accured Expenses fell 10467.05% to -$270.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.3 billion, marking a year-over-year decrease of 22064.23%. This contributed to the annual value of $1.6 billion for FY2024, which is 7099.14% down from last year.
  • Johnson & Johnson's Change in Accured Expenses amounted to -$270.0 million in Q3 2025, which was down 10467.05% from $583.0 million recorded in Q2 2025.
  • In the past 5 years, Johnson & Johnson's Change in Accured Expenses registered a high of $6.3 billion during Q2 2023, and its lowest value of -$6.5 billion during Q1 2025.
  • Moreover, its 5-year median value for Change in Accured Expenses was -$585.0 million (2024), whereas its average is $45.7 million.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first tumbled by 94019.61% in 2021, then soared by 821707.32% in 2023.
  • Over the past 5 years, Johnson & Johnson's Change in Accured Expenses (Quarter) stood at $2.1 billion in 2021, then tumbled by 233.38% to -$2.8 billion in 2022, then soared by 218.14% to $3.3 billion in 2023, then plummeted by 132.81% to -$1.1 billion in 2024, then surged by 75.27% to -$270.0 million in 2025.
  • Its Change in Accured Expenses was -$270.0 million in Q3 2025, compared to $583.0 million in Q2 2025 and -$6.5 billion in Q1 2025.